Response to Letter to the Editor Regarding “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal”
Crossref DOI link: https://doi.org/10.1007/s40273-017-0507-3
Published Online: 2017-04-08
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ramaekers, Bram L. T. http://orcid.org/0000-0001-5785-9228
Riemsma, Rob
Tomini, Florian
van Asselt, Thea
Deshpande, Sohan
Duffy, Steven
Armstrong, Nigel
Severens, Johan L.
Kleijnen, Jos
Joore, Manuela A.
Text and Data Mining valid from 2017-04-08